首页> 外文期刊>Japanese journal of clinical oncology. >Surgical resection of pulmonary metastases from colorectal cancer: Four favourable prognostic factors.
【24h】

Surgical resection of pulmonary metastases from colorectal cancer: Four favourable prognostic factors.

机译:结直肠癌的肺转移的手术切除:四个有利的预后因素。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Surgical resection has been the first choice for treatment of pulmonary metastases from colorectal cancer; however, indications for surgery have yet to be adequately clarified. In considering strategies for the treatment of pulmonary metastases from colorectal carcinoma, determination of disease status as either systemic or pre-systemic is of primary importance. The aim of this study is to define the characteristics of those patients who are most likely to benefit from surgical resection. METHODS: Fifty-eight patients who underwent pulmonary resection for colorectal metastases were retrospectively reviewed and examined for clinicopathological factors. RESULTS: Overall, 5-year survival rates were 29%, with a median survival time (MST) of 27 months. Multivariate analysis identified four factors that indicate independent and favourable prognostic impact: three or less tumours, metachronous metastasis, negative hilar and/or mediastinal lymph node metastasis and normal prethoracotomy serum carcinoembryonic antigen level. The 5-year survival rate for 16 patients who satisfied all of these favourable characteristics was 62% (MST = 86 months), which was significantly better than those patients lacking these characteristics. The 5-year survival rate for 13 patients who underwent repeated metastasectomy was 37% (MST = 32 months). CONCLUSIONS: The four factors selected in our multivariate analysis appear to be favourable factors for the practical identification of those patients who are most likely to benefit from surgical resection. Repeated pulmonary resection for lung-only recurrence may benefit carefully selected patients.
机译:背景:手术切除已成为治疗结直肠癌肺转移的首选方法。然而,手术的适应症尚待充分阐明。在考虑治疗来自大肠癌的肺转移的策略时,确定系统性还是全身性疾病状态至关重要。这项研究的目的是确定最有可能从手术切除中受益的那些患者的特征。方法:对58例因结直肠转移而行肺切除术的患者进行回顾性检查,并检查其临床病理因素。结果:总体而言,5年生存率为29%,中位生存时间(MST)为27个月。多变量分析确定了表明独立和有利的预后影响的四个因素:三个或更少的肿瘤,异时转移,肝门和/或纵隔淋巴结转移阴性,开胸手术前血清癌胚抗原水平正常。满足所有这些良好特征的16名患者的5年生存率为62%(MST = 86个月),明显优于那些缺乏这些特征的患者。 13例行反复转移灶切除术的患者的5年生存率为37%(MST = 32个月)。结论:在我们的多元分析中选择的四个因素似乎是对那些最有可能从手术切除中受益的患者进行实际鉴定的有利因素。对于仅肺部复发的重复肺切除术可能有益于精心选择的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号